Business
Result of GM and Change of Name to Evocutis plc
Result of GM and Change of Name to Evocutis plc.
About this update from Gunsynd Plc
[{"type":"text","content":"\n \nRNS Number : 5770Q Syntopix Group plc 20 October 2011 \n \n\n \n \n \n\n\n\n\nPress Release \n\n\n20 October 2011\n\n\n\n\n \nSyntopix Group plc (to be renamed Evocutis plc)\n(\"the Company\")\n \nResult of General Meeting and Change of Name to Evocutis plc\n \n \nOn 27 September 2011, Syntopix Group plc (AIM:SYN), the dermatological experts delivering healthcare innovation to the cosmetic, consumer healthcare and pharmaceutical industries, announced a proposed change of name of the Company from Syntopix Group plc to Evocutis plc, conditional upon the passing of a resolution by shareholders at a general meeting of the Company. \n \nThe directors of the Company are pleased to announce that shareholders approved the resolution earlier today.\n \nIt is expected that the Company will change its name to Evocutis plc, its AIM symbol to EVO and its website address to www.evocutis.com with effect from 7.00am on Tuesday 25th October 2011.\n \n- Ends -\nFor further information, please contact:\n\n\n\n\nSyntopix Group plc \n(to be renamed Evocutis plc)\n\n\n\n\n\n \n\n\n\n\nDr Stephen Jones, Chief Executive Officer\n\n\n+44 (0)845 125 9204\n\n\n \n\n\n\n\nTom Bannatyne, Chairman\n\n\n\n\n\n \n\n\n\n\n \nZeus Capital Ltd\n\n\n\n\n\n\n\nTom Rowley/Andrew Jones\n\n\nTel: +44(0)161 831 1512 \n\n\n\n\n\n\n\nwww.zeuscapital.co.uk\n\n\n\n\n \n\n\n\n\nXCAP Securities Plc\n\n\n\n\n\n\n\nKaren Kelly/John Grant\n\n\nTel: +44(0) 207 101 7070 \n\n\n\n\n\n\n\nwww.xcapgroup.co.uk\n\n\n\n\n \nMedia enquiries:\n\n\n\n\nAbchurch Communications\n\n\n\n\n\n\n\nSarah Hollins/Adam Michael/ Jamie Hooper\n\n\nTel: +44 (0) 20 7398 7719\n\n\n\n\[email protected]\n\n\nwww.abchurch-group.com\n\n\n\n\n \nNotes to editors\nAbout Evocutis plc\nWith a rich portfolio of new product opportunities Evocutis offers antimicrobial expertise to the cosmetic, consumer healthcare and pharmaceutical industries. \nAdditionally, Evocutis is uniquely able to combine research for laboratory testing, advanced skin models and clinical testing to offer a complete service for the development of skin care products and ingredients. Through research and testing we enable ...